Publication | Open Access
Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI
108
Citations
43
References
2021
Year
A red blood cell-derived extracellular vesicle platform targeted Kim-1 in acutely injured mouse kidney and delivered siRNAs for transcription factors <i>P65</i> and <i>Snai1</i>, alleviating inflammation and fibrosis in the tubules.
| Year | Citations | |
|---|---|---|
Page 1
Page 1